Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats
- PMID: 19824823
- PMCID: PMC3135248
- DOI: 10.1089/scd.2009.0319
Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats
Abstract
Cell replacement therapy could be an important treatment strategy for Parkinson's disease (PD), which is caused by the degeneration of dopamine neurons in the midbrain (mDA). The success of this approach greatly relies on the discovery of an abundant source of cells capable of mDAergic function in the brain. With the paucity of available human fetal tissue, efforts have increasingly focused on renewable stem cells. Human induced pluripotent stem (hiPS) cells offer great promise in this regard. If hiPS cells can be differentiated into authentic mDA neuron, hiPS could provide a potential autologous source of transplant tissue when generated from PD patients, a clear advantage over human embryonic stem (hES) cells. Here, we report that mDA neurons can be derived from a commercially available hiPS cell line, IMR90 clone 4, using a modified hES differentiation protocol established in our lab. These cells express all the markers (Lmx1a, Aldh1a1, TH, TrkB), follow the same mDA lineage pathway as H9 hES cells, and have similar expression levels of DA and DOPAC. Moreover, when hiPS mDA progenitor cells are transplanted into 6-OHDA-lesioned PD rats, they survive long term and many develop into bona fide mDA neurons. Despite their differentiation and integration into the brain, many Nestin+ tumor-like cells remain at the site of the graft. Our data suggest that as with hES cells, selecting the appropriate population of mDA lineage cells and eliminating actively dividing hiPS cells before transplantation will be critical for the future success of hiPS cell replacement therapy in PD patients.
Figures




Similar articles
-
Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.Stem Cells. 2013 Aug;31(8):1548-62. doi: 10.1002/stem.1415. Stem Cells. 2013. PMID: 23666606 Free PMC article.
-
The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.Stem Cells. 2009 Jan;27(1):220-9. doi: 10.1634/stemcells.2008-0734. Stem Cells. 2009. PMID: 18832589
-
Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.Cytotherapy. 2015 May;17(5):665-79. doi: 10.1016/j.jcyt.2015.02.001. Epub 2015 Mar 5. Cytotherapy. 2015. PMID: 25747741
-
Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.Cells. 2020 Jun 18;9(6):1489. doi: 10.3390/cells9061489. Cells. 2020. PMID: 32570916 Free PMC article. Review.
-
Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.J Mol Neurosci. 2004;24(3):353-86. doi: 10.1385/JMN:24:3:353. J Mol Neurosci. 2004. PMID: 15655260 Review.
Cited by
-
In vitro maturation of dopaminergic neurons derived from mouse embryonic stem cells: implications for transplantation.PLoS One. 2012;7(2):e31999. doi: 10.1371/journal.pone.0031999. Epub 2012 Feb 22. PLoS One. 2012. PMID: 22384125 Free PMC article.
-
Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications.Stem Cell Reports. 2016 Sep 13;7(3):557-570. doi: 10.1016/j.stemcr.2016.07.017. Epub 2016 Aug 25. Stem Cell Reports. 2016. PMID: 27569063 Free PMC article.
-
Missing pieces in the Parkinson's disease puzzle.Nat Med. 2010 Jun;16(6):653-61. doi: 10.1038/nm.2165. Epub 2010 May 23. Nat Med. 2010. PMID: 20495568 Review.
-
Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.Stem Cells Dev. 2017 Oct 1;26(19):1409-1423. doi: 10.1089/scd.2017.0059. Epub 2017 Aug 22. Stem Cells Dev. 2017. PMID: 28693365 Free PMC article.
-
A systematic review of progenitor survival and maturation in Parkinsonian models.Neural Regen Res. 2025 Nov 1;20(11):3172-3178. doi: 10.4103/NRR.NRR-D-24-00894. Epub 2024 Nov 13. Neural Regen Res. 2025. PMID: 39589166 Free PMC article.
References
-
- Lie DC. Colamarino SA. Song HJ. Désiré L. Mira H. Consiglio A. Lein ES. Jessberger S. Lansford H. Dearie AR. Gage FH. Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005;437:1370–1375. - PubMed
-
- Lindvall O. Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006;441:1094–1096. - PubMed
-
- Iacovitti L. Stull ND. Expression of tyrosine hydroxylase in newly differentiated neurons from a human cell line (hNT) Neuroreport. 1997;8:1471–1474. - PubMed
-
- Iacovitti L. Stull ND. Jin H. Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line. Brain Res. 2001;912:99–104. - PubMed
-
- Stull ND. Jung JW. Iacovitti L. Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Brain Res Dev Brain Res. 2001;130:91–98. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous